Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Tatva Chintan Pharma Chem Limited (NSE: TATVA), ISIN INE0GK401011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TATVA last traded at ₹1655.60 (+3.10%), with a 52-week range of ₹1044.10 to ₹2113.60 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 72.02%, FIIs 4.38%, DIIs 3.21%, mutual funds 2.87%.
EquiSense Score (ECS): 80/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.